Evidence-Based Benefits
- OA pain reduction — Bruyere et al. (2012, n=200) found 1,200mg/day collagen hydrolysate (including type II) significantly reduced knee OA pain and improved function over 6 months vs. placebo
- Cartilage biomarker improvement — Clark et al. (2008, n=147) showed 10g/day collagen hydrolysate improved cartilage integrity markers in athletes with activity-related joint pain over 24 weeks
- Chondrocyte stimulation — bioactive collagen peptides (particularly those containing hydroxyproline) are absorbed intact and stimulate chondrocytes to increase type II collagen and proteoglycan synthesis
- Complementary amino acid profile — type II collagen is uniquely rich in glycine, proline, and hydroxyproline, the amino acids most needed for cartilage collagen synthesis, in ratios not found in regular dietary protein
- Joint structure support — Zhu et al. (2018, meta-analysis of 5 RCTs) concluded collagen hydrolysate significantly reduced WOMAC total scores and improved OA outcomes